We hypothesized that xCT may be a novel therapeutic target for memory disorder and depression-like phenotype, and investigated the effect of sulfasalazine (SSZ) on PSNPI (Fig. 6a–d). The gene discussed is SLC7A11; the disease is major depressive disorder.